Leerink Swann upgraded Actavis (NYSE: ACT) from Market Perform to Outperform with a price target of $155.00 (from $133.00), saying ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE